CHAP II therapy for epithelial ovarian cancers following primary treatment with platinum-based combination chemotherapy
Authors:
- Peter E. SchwartzPSPeter E. Schwartz
- Gertrude KeatingGKGertrude Keating
- Ernest I. KohornEKErnest I. Kohorn
- Joseph T. ChambersJCJoseph T. Chambers
- 1 November 1986
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 25 (3) , 340-346
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Cis-platin based combination chemotherapy for advanced ovarian cancer. High overall response rate with curative potential only in women with small tumor burdensCancer, 1983
- A prospective randomized clinical trial of melphalan and cis-platinum versus hexamethylmelamine, adriamycin, and cyclophosphamide in advanced ovarian cancerGynecologic Oncology, 1983
- TAMOXIFEN THERAPY FOR ADVANCED OVARIAN-CANCER1982
- ESTROGEN-RECEPTORS IN OVARIAN EPITHELIAL CARCINOMA1982
- Serial Assessment of Doxorubicin Cardiotoxicity with Quantitative Radionuclide AngiocardiographyNew England Journal of Medicine, 1979